Three projects leveraging AllerGen’s Canadian Healthy Infant Longitudinal Development (CHILD) Study have been awarded 5-year grants, valued at over $5.6 million, from the Canadian Institutes of Health Research (CIHR).
The grants are part of a broader government initiative to combat chronic health conditions.
The CHILD Study follows a Canadian longitudinal birth cohort study of 3500 children (born after 2010) to look at the influences of genetic predisposition and environmental factors on children’s development. Areas of research in the CHILD Study include food allergies and asthma.
One study, led by Dr. Stuart Turvey of the University of British Columbia, will investigate how a child’s environment interacts with the genome in the development of asthma. Another, led by Dr. Padmaja Subbarao of the University of Toronto, will study gene and environment effects on lung health and the risk for chronic respiratory disease, asthma and COPD.
A third project, led by Dr. Vern Dolinsky (University of Manitoba), deals with childhood obesity.
We are excited to see new research into asthma being funded by the Government of Canada and we will keep you posted as we learn more.
Read the press release.Tags: asthma, CHILD Study